Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Multicenter randomized double blind trial comparing intravenous cangrelor and oral ticagrelor
in patients with acute myocardial infarction complicated by initial cardiogenic shock and
treated with primary angioplasty.